Detalhe da pesquisa
1.
Outcomes of second-line treatment after fludarabine cyclophosphamide and rituximab in patients with chronic lymphocytic leukemia outside clinical trials.
Eur J Haematol
; 101(3): 399-406, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29949186
2.
Efficacy and safety of front-line therapy with fludarabine-cyclophosphamide-rituximab regimen for chronic lymphocytic leukemia outside clinical trials: the Israeli CLL Study Group experience.
Haematologica
; 100(5): 662-9, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25661442